Latest BPH Stories

INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of Cialis® (tadalafil) tablets 5 mg for once a day use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). The CHMP's opinion is now referred to the European Commission, which has the authority to approve...

SAN DIEGO, CA and VANCOUVER, Aug. 31, 2012 /PRNewswire/ - Sophiris Bio Inc. (TSX: SHS) today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection. The results support the use of a transrectal ultrasound (TRUS) guided injection for the delivery of PRX302 directly into the prostate. This...

MINNETONKA, Minn., Aug. 21, 2012 /PRNewswire/ -- American Medical Systems (AMS), an Endo Health Solutions (Nasdaq: ENDP) company and a leading provider of devices and therapies for male and female pelvic health, today introduced the new 650kJ MoXy(®) fiber for its class-leading GreenLight XPS(®) system for photoselective vaporization of the prostate. Providing more than 50 percent more energy than the previous fiber for the same price, the new MoXy fiber will enable physicians to...

HoLEP attains rapid adoption and acceptance as the Proven Procedure for Treating BPH Yokneam, Israel (PRWEB) May 19, 2012 Lumenis Ltd., the world's largest medical laser company developing, manufacturing and distributing a broad range of medical lasers and sophisticated energy delivery equipment for surgical, aesthetic and ophthalmic applications, announces that it will feature distinguished speakers from around the globe who will share their insights into the latest advances in surgical...

The use of saw palmetto in patients with benign prostatic hyperplasia (BPH) improves not only urinary symptoms but also concomitant sexual dysfunctions, latest research shows. Roggwil, Switzerland (PRWEB) May 11, 2012 A new study – published in the journal Phytotherapy Research -- showed for the first time that a treatment with a saw palmetto preparation (Prostasan®) lead to an improvement not only of urinary symptoms but also of sexual dysfunctions.Benign prostatic hyperplasia...

TURP Device Sales in Spain, France and the U.K. Drive Growth in the BPH Treatment Market VANCOUVER, April 24, 2012 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device market research, the European urological device market, was valued at over EUR1 Billion in 2011. Growth will be fueled by increased sales of robotic prostatectomy for the treatment of prostate cancer, particularly in Germany and Italy....

INDIANAPOLIS, Feb. 7, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a Phase III study, published online by European Urology, showed both Cialis® (tadalafil) and tamsulosin significantly improved scores on the International Prostate Symptom Score (IPSS), compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia (BPH). Cialis improved erectile dysfunction (ED) in those men who had both signs and symptoms of BPH...

PLEASANTON, Calif., Jan. 9, 2012 /PRNewswire/ -- NeoTract, Inc., a medical device company developing new urology devices, today announced completion of enrollment in the FDA-approved L.I.F.T. Study for men with urinary tract symptoms due to benign prostatic hyperplasia (BPH). This multi-national study enrolled 206 men, age 50 or older, and was randomized 2:1 to the UroLift® System versus control. The UroLift System is being investigated as a minimally invasive device designed to...

CAPE CORAL, Fla., Dec. 8, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures, Inc. (MILV.pk) announced that it has developed a new formula that promotes prostate health. According to the National Institutes of Health (NIH), enlarged prostate -- clinically known as benign prostatic hyperplasia (BPH) -- is a "common part of aging" for men. In fact, the NIH estimates that "more than half of men in their 60s, and as many as 90% in their 70s and...

Study covered more than 6,000 men with urological emergency Men who experience a sudden inability to pass urine because of a non-cancerous enlarged prostate are hospitalised and treated differently depending on where they live, according to an international study published online by the urology journal BJUI. The paper, which will appear in the January issue, reports on how nearly 1,000 clinicians in 15 countries responded to this urological emergency in more than 6,000 men. "Acute...